title: Treatment of hairy cell leukemia during pregnancy: are purine analogues and rituximab viable therapeutic options.
authors.affiliation: Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. ndaver@mdanderson.org
authors.forename: Naval
authors.initials: N
authors.lastname: Daver
authors.forename: Aziz
authors.initials: A
authors.lastname: Nazha
authors.forename: Hagop M
authors.initials: HM
authors.lastname: Kantarjian
authors.forename: Rodney
authors.initials: R
authors.lastname: Haltom
authors.forename: Farhad
authors.initials: F
authors.lastname: Ravandi
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D017338:Cladribine / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007943:Leukemia, Hairy Cell / Q000188:drug therapy*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy*; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D017338:Cladribine; D000069283:Rituximab